Redfin (RDFN) shares soared 80% pre-bell Monday after the company agreed to be acquired by Rocket Companies (RKT) in a deal worth $1.75 billion.
Checkpoint Therapeutics (CKPT) shares surged 67% after the company agreed to be acquired by India's Sun Pharmaceutical Industries for $4.10 per share in cash plus a contingent value right.
Trevi Therapeutics (TRVI) shares advanced 32% after the company said its phase 2a trial of Haduvio for the treatment of patients with refractory chronic cough met its primary endpoint.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。